-
FDA panel recommends approval for two Novo Nordisk insulin products
BAGSVÆRD, Denmark — A Food and Drug Administration panel has voted to support two experimental insulin treatments made by Novo Nordisk, the Danish drug maker said Thursday.
Novo Nordisk said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee had voted 8-to-4 in favor of approval for insulin degludec and a combination treatment containing insulin degludec and insulin aspart.
-
GSK donates $250,000 to American National Red Cross, pledges more support to Sandy victims
PHILADELPHIA &,dash; GlaxoSmithKline on Friday donated $250,000 to the American National Red Cross to help victims of Hurricane Sandy. The company also is contributing $80,000 through the British Red Cross for relief efforts in the wider Caribbean region — specifically Haiti, Cuba, Jamaica and the Dominican Republic — where Sandy initially made landfall.